Form 8-K - Current report:
SEC Accession No. 0001104659-18-032365
Filing Date
2018-05-11
Accepted
2018-05-11 07:05:44
Documents
3
Period of Report
2018-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-13287_18k.htm 8-K 24266
2 EX-99.1 a18-13287_1ex99d1.htm EX-99.1 124367
3 GRAPHIC g132871mm01i001.jpg GRAPHIC 2832
  Complete submission text file 0001104659-18-032365.txt   153909
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 18824902
SIC: 2834 Pharmaceutical Preparations